Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies

Documenti analoghi

• Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
  di: Emma M. Bentley, et al.
  Pubblicazione: (2021-08-01)
• Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
  di: Wesley V Cain, et al.
  Pubblicazione: (2022-01-01)
• Symptom-Based Ebola Risk Score for Ebola Virus Disease, Conakry, Guinea
  di: Brecht Ingelbeen, et al.
  Pubblicazione: (2018-06-01)
• Ebola virus antibody decay–stimulation in a high proportion of survivors
  di: Adaken, C, et al.
  Pubblicazione: (2021)
• Studies of Ebola Virus persistence in the Body Fluids of a Patient at Advanced Stages of Convalescence
  di: A. A. Lopatin, et al.
  Pubblicazione: (2015-09-01)